Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
841 days ago
Australia Data Due On Friday
Australia will on Friday release Q1 figures for producer prices and March numbers for retail sales, highlighting a busy day for Asia-Pacific economic activity.
RTTNews
|
7 minutes ago
Pound Rises Against Most Majors
The pound firmed against its most major counterparts in the New York session on Thursday.
RTTNews
|
4h 13min ago
UK Market Ends Slightly Up
On a day in which most of the markets across Europe remained closed for Labor Day holiday, the UK market, where trading was on, ended marginally up on Thursday, extending its gains to a 13th straight session.
RTTNews
|
5h 8min ago
Canadian Market Retreats After Recovering From Early Drop
The Canadian market is modestly higher around noon on Thursday with shares from energy and technology sectors posting strong gains. A sell-off in materials section is limiting market's upside.
The mood in the market is quite cautious amid concerns about global economic growth.
RTTNews
|
5h 50min ago
U.S. Construction Spending Unexpectedly Falls 0.5% In March
Construction spending in the U.S. unexpectedly decreased in the month of March, the Commerce Department revealed in a report released on Thursday. The Commerce Department said construction spending fell by 0.5 percent to an annual rate of $2.196 trillion in March after climbing by 0.6 percent to a revised rate of $2.207 trillion in February.
RTTNews
|
7h 33min ago
U.S. Manufacturing Index Dips Slightly Further Into Contraction Territory In April
The Institute for Supply Management released a report on Thursday showing a slight decrease by its reading on U.S. manufacturing activity in the month of April. The ISM said its manufacturing PMI edged down to 48.7 in April after slipping to 49.0 in March, with a reading below 50 indicating contraction. Economists had expected the index to dip to 48.0.
RTTNews
|
7h 46min ago
U.S. Jobless Claims Rise Much More Than Expected To Two-Month High
A report released by the Labor Department on Thursday showed first-time claims for U.S. unemployment benefits rose by much more than expected in the week ended April 26th. The Labor Department said initial jobless claims climbed to 241,000, an increase of 18,000 from the previous week's revised level of 223,000.
RTTNews
|
7h 57min ago
